Technetium Tc 99m sestamibi myocardial perfusion imaging: Current role for evaluation of prognosis

Chest

Volumn 115, Issue 6, 1999, Pages 1684-1694

  Mandalapu, Bhuvana P ^a   Amato, Maryellen ^a   Stratmann, Henry G ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Coronary disease; Dipyridamole; Exercise test; Prognosis; Single photon emission CT; Technetium 99m sestamibi

Indexed keywords

DIPYRIDAMOLE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

CORONARY ARTERY DISEASE; EMERGENCY WARD; EXERCISE TEST; HEART DEATH; HEART INFARCTION; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

EID: 0033039947     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.6.1684     Document Type: Article

References (77)

1. 201Tl myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 1991; 83:363-381
2. 2 Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol 1996; 3:516-537
3. 3 Shaw LJ, Peterson ED, Kesler K, et al. A meta-analysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol 1996; 78: 1327-1337
4. 4 Shaw LJ, Eagle KA, Gersh BJ, et al. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol 1996:27:787-798
5. 5 Gill JB, Ruddy TD, Newell JB, et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease. N Engl J Med 1987; 317:1486-1489
6. 6 Van Tosh A, Hecht S, Berger M, et al. Exercise echocardiographic correlates of transient dilatation of the left ventricular cavity on exercise thallium-201 SPECT imaging. Chest 1994; 106:1725-1729
7. 7 Maddahi J, Kiat H, Van Train KF, et al. Myocardial perfusion imaging with technetium-99m sestamibi SPECT in the evaluation of coronary artery disease. Am J Cardiol 1990; 66:55E-62E
8. 8 Sochor H. Technetium-99m sestamibi in chronic coronary artery disease: the European experience. Am J Cardiol 1990; 66:91E-96E
9. 9 Berman DS, Kiat H, Van Train KF, et al. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability. Am J Cardiol 1990; 66:72E-79E
10. 10 Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996; 93:905-914
11. 11 Berman DS, Hachamovitch R, Kiat H, et al. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995; 26:639-647
12. 12 Hassan IM, Mohammed MM, Constantinides C, et al. Segmental analysis of SPECT 99mTc-methoxy isobutyl isonitrile and 201Tl myocardial imaging in ischemic heart disease. Eur J Nucl Med 1990; 16:705-711
13. 13 Gersh BJ, Braunwald E, Rutherford JD. Chronic coronary artery disease. In: Braunwald E, ed. Heart disease. Philadelphia, PA: WB Saunders, 1997; 1289-1365
14. 14 Thorn TJ, Kannel WB, Silbershatz H, et al. Incidence, prevalence, and mortality of cardiovascular diseases in the United States. In: Alexander RW, Schlant RC, Fuster V, et al, ed. Hurst's the heart. New York, NY: McGraw-Hill, 1998; 3-17
15. 15 Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing: executive summary - a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation 1997; 96:345-354
16. 16 Morris CK, Ueshima K, Kawaguchi T, et al. The prognostic value of exercise capacity: a review of the literature. Am Heart J 1991; 122:1423-1431
17. 17 Pollock SG, Abbott RD, Boucher CA, et al. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: validation of models based on these tests. Circulation 1992; 85:237-248
18. 18 Iskandrian AS, Chae SC, Heo J, et al. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993; 22:665-670
19. 19 Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium-99m sestamibi tomography for cardiac risk stratiflcation of patients with stable chest pain. Circulation 1994; 89:615-622
20. 20 Brown KA, Altland E, Rowen M. Prognostic value of normal technetium-99m-sestamibi cardiac imaging. J Nucl Med 1994; 35:554-557
21. 21 Boyne TS, Koplan BA, Parsons WJ, et al. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol 1997; 79:270-274
22. 22 Raiker K, Sinusas AJ, Wackers FJ, et al. One-year prognosis of patients with normal planar or single-photon emission computed tomographic technetium 99m-labeled sestamibi exercise imaging. J Nucl Cardiol 1994; 1:449-456
23. 23 Zanco P, Zampiero A, Favero A, et al. Myocardial technetium-99m sestamibi single-photon emission tomography as a prognostic tool in coronary artery disease: multivariate analysis in a long-term prospective study. Eur J Nucl Med 1995; 22:1023-1028
24. 24 Desideri A, Candelpergher G, Zanco P, et al. Exercise technetium 99m sestamibi single-photon emission computed tomography late after coronary artery bypass surgery: long-term follow-up. Clin Cardiol 1997; 20:779-784
25. 25 Nallamouthu N, Araujo L, Russell J, et al. Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi. Am J Cardiol 1996; 78:562-564
26. 26 Hachamovitch R, Berman DS, Kiat H, et al. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 1996; 28:34-44
27. 27 Travin MI, Duca MD, Kline GM, et al. Relation of gender to physician use of test results and to the prognostic value of stress technetium 99m sestamibi myocardial single-photon emission computed tomography scintigraphy. Am Heart J 1997; 134:73-82
28. 28 Alkeylani A, Miller DD, Shaw LJ, et al. Influence of race upon the prediction of cardiac events with stress Tc-99m sestamibi tomographic imaging in patients with stable angina pectoris. Am J Cardiol 1998; 31:312-320
29. 29 Brown KA. Prognostic value of cardiac imaging in patients with known or suspected coronary artery disease: comparison of myocardial perfusion imaging, stress echocardiography, and position emission tomography. Am J Cardiol 1995; 75:35D-41D
30. 30 Pellikka PA. Stress echocardiography in the evaluation of chest pain and accuracy in the diagnosis of coronary artery disease. Prog Cardiovasc Dis 1997; 39:523-532
31. 31 O'Keefe JH Jr, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol 1995; 75:25D-34D
32. 32 Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiography for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol 1997; 30:83-90
33. 33 Sawada SG, Ryan T, Conley MJ, et al. Prognostic value of a normal exercise echocardiogram. Am Heart J 1990; 120: 49-55
34. 34 Ismail G, Lo E, Sada M, et al. Long-term prognosis of patients with a normal exercise echocardiogram and clinical suspicion of myocardial ischemia. Am J Cardiol 1995; 75:934-936
35. 35 Marcovitz PA. Prognostic issues in stress echocardiography. Prog Cardiovasc Dis 1997; 39:533-542
36. 36 Yao Z, Liu XJ, Shi R, et al. A comparison of 99mTc-MIBI myocardial SPET with electron beam computed tomography in the assessment of coronary artery disease. Eur J Nucl Med 1997; 24:1115-1120
37. 37 Budoff MJ, Gillespie R, Georgiou D, et al. Comparison of exercise electron beam computed tomography and sestamibi in the evaluation of coronary artery disease. Am J Cardiol 1998; 81:682-687
38. 38 Prigent FM, Steingart RM. Clinical value of electron-beam computed tomography in the diagnosis and prognosis of coronary artery disease. Curr Opin Cardiol 1997; 12:561-565
39. 39 Secci A, Wong N, Tang W, et al. Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation 1997; 96: 1122-1129
40. 40 Detrano R, Hsiai T, Wang S, et al. Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography. J Am Coll Cardiol 1996; 27:285-290
41. 41 Stratmann HG, Tamesis BR, Younis LT, et al. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994; 73:647-652
42. 42 Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995; 26:1202-1208
43. 43 McClellan JR, Travin MI, Herman SD, et al. Prognostic importance of scintigraphic left ventricular cavity dilation during intravenous dipyridamole technetium-99m sestamibi myocardial tomographic imaging in predicting coronary events. Am J Cardiol 1997; 79:600-605
44. 44 Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997; 80:426-433
45. 45 Senior R, Raval U, Lahiri A. Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease. Am J Cardiol 1996; 78:1092-1096
46. 46 Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain. J Am Coll Cardiol 1996; 28:447-454
47. 47 Geleijnse ML, Elhendy A, van Domburg RT, et al. Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain. Am J Cardiol 1996; 77:1057-1061
48. 48 Braunwald E, Mark DB, Jones RH, et al. Unstable angina: diagnosis and management. Clinical Practice Guidelines No. 10. Agency for Health Care Policy and Research, Publication No. 94-0602. Rockville, MD: US Department of Health and Human Services, 1994
49. 49 Madsen JK, Stubgaard M, Utne HE, et al. Prognosis and thallium-201 scintigraphy in patients admitted with chest pain without confirmed acute myocardial infarction. Br Heart J 1988; 59:184-189
50. 50 Brown KA. Prognostic value of thallium-201 myocardial perfusion imaging in patients with unstable angina who respond to medical treatment. J Am Coll Cardiol 1991; 17:1053-1057
51. 51 Younis LT, Byers S, Shaw L, et al. Prognostic value of intravenous dipyridamole thallium scintigraphy after an acute myocardial ischemic event. Am J Cardiol 1989; 64:161-166
52. 52 Zhu YY, Chung WS, Botvinick EH, et al. Dipyridamole perfusion scintigraphy: the experience with its application in one hundred seventy patients with known or suspected unstable angina. Am Heart J 1991; 121:33-43
53. 53 Stratmann HG, Tamesis BR, Younis LT, et al. Prognostic value of pre-hospital discharge dipyridamole technetium-99m sestamibi myocardial tomography in medically treated patients with unstable angina. Am Heart J 1995; 130:734-740
54. 54 Stratmann HG, Younis LT, Wittry MD, et al. Exercise technetium-99m myocardial tomography for the risk stratification of men with medically treated unstable angina pectoris. Am J Cardiol 1995; 76:236-240
55. 55 Travin MI, Dessouki A, Cameron T, et al. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 1995; 75:665-669
56. 56 Stratmann HG, Mark AL, Amato ME, et al. Risk stratification using pre-hospital discharge exercise technetium-99m sestamibi myocardial tomography in men after acute myocardial infarction. Am Heart J 1998; 136:87-93
57. 57 Heller GV, Brown KA, Landin RJ, et al. Safety of early intravenous dipyridamole technetium 99m sestamibi SPECT myocardial perfusion imaging after uncomplicated first myocardial infarction: Early Post MI IV Dipyridamole Study (EPIDS). Am Heart J 1997; 134:105-111
58. 58 van Daele ME, McNeill AJ, Fioretti PM, et al. Prognostic value of dipyridamole sestamibi single-photon emission computed tomography and dipyridamole stress echocardiography for new cardiac events after an uncomplicated myocardial infarction. J Am Soc Echocardiogr 1994; 7:370-380
59. 59 Boucher CA, Brewster DC, Darling RC, et al. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med 1985; 312:389-394
60. 60 Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med 1989; 110:859-866
61. 61 Hendel RC, Whitfield SS, Villegas BJ, et al. Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol 1992; 70:1243-1249
62. 62 Lette J, Watters D, Lassonde J, et al. Multivariate clinical models and quantitative dipyridamole-thallium imaging to predict cardiac morbidity and death after vascular reconstruction. J Vasc Surg 1991; 14:160-169
63. 63 Mangano DT, London MJ, Tubau JF, et al. Thallium-201 scintigraphy as a preoperative screening test: a reexamination of its predictive potential. Circulation 1991; 84:493-502
64. 64 Marwick TH, Underwood DA. Dipyridamole thallium imaging may not be a reliable screening test for coronary artery disease in patients undergoing vascular surgery. Clin Cardiol 1990; 13:14-18
65. 65 Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med 1994; 330:663-669
66. 66 de Virgilio C, Pak S, Arnell T, et al. Cardiac assessment prior to vascular surgery: is dipyridamole-sestamibi necessary? Ann Vasc Surg 1996; 10:325-329
67. 67 Stratmann HG, Younis LT, Wittry MD, et al. Dipyridamole technetium-99m sestamibi myocardial tomography in patients evaluated for elective vascular surgery: prognostic value for perioperative and late cardiac events. Am Heart J 1996; 131:923-929
68. 68 Stratmann HG, Younis LT, Wittry MD, et al. Dipyridamole technetium-99m sestamibi myocardial tomography for preoperative cardiac risk stratification prior to major or minor nonvascular surgery. Am Heart J 1996; 132:536-541
69. 69 Maunoury C, Stone DA, Chen CC, et al. Preoperative cardiac risk assessment with adenosine stress dual-isotope myocardial single-photon emission computed tomography. Clin Cardiol 1996; 19:488-490
70. 70 Van Damme H, Pierard L, Gillain D, et al. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy. Cardiovasc Surg 1997; 5:54-64
71. 71 Hilton TC, Thompson RC, Williams HJ, et al. Technetium-99m sestamibi myocardial perfusion imaging in the emergency room evaluation of chest pain. J Am Coll Cardiol 1994; 23:1016-1022
72. 72 Hilton TC, Fulmer H, Abuan T, et al. Ninety-day follow-up of patients in the emergency department with chest pain who undergo initial single-photon emission computed tomographic perfusion scintigraphy with technetium 99m-labeled sestamibi. J Nucl Cardiol 1996; 3:308-311
73. 73 Radensky PW, Hilton TC, Fulmer H, et al. Potential cost effectiveness of initial myocardial perfusion imaging for assessment of emergency department patients with chest pain. Am J Cardiol 1997; 79:595-599
74. 74 Varetto T, Cantalupi D, Altieri A, et al. Emergency room technetium-99m sestamibi imaging to rule out acute myocardial ischemic events in patients with nondiagnostic electrocardiograms. J Am Coll Cardiol 1993; 22:1804-1808
75. 75 Tatum JL, Jesse RL, Kontos MC, et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med 1997; 29:116-125
76. 76 Miller TD, Christian TF, Hopfenspirger MR, et al. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995; 92:334-341
77. 77 Kontos MC, Jesse RL, Schmidt KL, et al. Value of acute rest sestamibi perfusion imaging for evaluation of patients admitted to the emergency department with chest pain. J Am Coll Cardiol 1997; 30:976-982